Global Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Market 2018: Know What is the MOA, ROA??

Share this news:

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H2 2018

Basic Overview of Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Market:

Metabotropic glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) is a protein that in humans is encoded by the GRM4 gene. Along with GRM6, GRM7 and GRM8 it belongs to group III of the metabotropic glutamate receptor family. Group III receptors are linked to the inhibition of the cyclic AMP cascade. Activation of GRM4 has potential therapeutic benefits in the treatment of parkinson's disease. Splice variant “taste-GRM4” is involved in the perception of umami taste.

Metabotropic glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) pipeline Target constitutes close to seven molecules. Out of which approximately five molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in phase II, Phase I, diagnosing and Discovery stages are 1, 1, 2 and 1 respectively. Similarly, the universities' portfolio in preclinical stages contains two molecules, respectively. Report covers merchandise from therapy areas Central nervous system and immunology which include indications Parkinson's disease, induration, opium (Opioid) Addiction, Anxiety Disorders, autoimmune Disorders, Depression, Dyskinesia, Infantile Spasm (West Syndrome), obsessive-compulsive Disorder, Psychosis, status epilepticus and Substance (Drug) Abuse.

The prime objective of Metabotropic glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Market- Pipeline Review, H2 2018, Is to give a Basic data regarding the worldwide therapeutic landscape of Metabotropic glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4), Key players involved with pipeline review and targeted therapeutics covering drugs profile of Metabotropic glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) market.

Request for sample PDF copy of Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Market research report at:

https://bit.ly/2CiMIsH

Types of Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Market: VU-0418506, ADX-88178, JBPOS-0101, PXT-2331…

Scope of the Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Market Report:

- The report provides a snapshot of the global therapeutic landscape for Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4)

- The report reviews Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted therapeutics and enlists all their major and minor projects

- The report assesses Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news and deals related to Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted therapeutics

Have a query, ask Our Expert:

https://bit.ly/2S8ygt5

Reasons to buy Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Report

- Gain strategically vital competitor data, analysis, and insights to formulate effective R&D strategies

- Determine rising players with potentially strong product portfolio and build effective counter-strategies to gain competitive advantage

- Determine and understand the targeted therapy areas and indications for Metabotropic glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4)

- Determine the use of drugs for target identification and drug repurposing

- Determine potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the main focus areas of leading companies

- Plan mergers and acquisitions excellently by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline comes by understanding Metabotropic glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) development landscape

- Develop and design in-licensing and out-licensing methods by identifying prospective partners with the most enticing projects to boost and expand business potential and scope

Purchase the Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Market Report at (Single User License- 3500$):

https://bit.ly/2EtihSe

Detailed Table of Contents of Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Market:

Introduction

Global Markets Direct Report Coverage

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Overview

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Therapeutics Development

Products under Development by Stage of Development

Products under Development by Therapy Area

Products under Development by Indication

Products under Development by Companies

Products under Development by Universities/Institutes

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Therapeutics Assessment

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Companies Involved in Therapeutics Development

Addex Therapeutics Ltd

Domain Therapeutics SA

Lundbeck AS
Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Drug Profiles

ADX-88178 - Drug Profile

foliglurax - Drug Profile

JBPOS-0101 - Drug Profile

Product Description

Small Molecules to Agonize mGluR4 for Parkinson's Disease - Drug Profile

Small Molecules to Agonize mGLUR4 for Parkinson's Disease, Multiple Sclerosis and Autoimmune Diseases - Drug Profile

VU-0418506 - Drug Profile

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Dormant Products

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Product Development Milestones

Contact Info:
Name: Mr. Ajay More
Email: Send Email
Organization: Market Reports World
Address: Baner, Pune
Phone: +1 408 520 9750
Website: https://www.marketreportsworld.com

Release ID: 461322

CONTACT ISSUER
Name: Mr. Ajay More
Email: Send Email
Organization: Market Reports World
Address: Baner, Pune
SUBSCRIBE FOR MORE